A geospatial study of the coverage of catheterization laboratory facilities (cath labs) and the travel time required to reach them in East Java, Indonesia
-
Published:2023-05-25
Issue:1
Volume:18
Page:
-
ISSN:1970-7096
-
Container-title:Geospatial Health
-
language:
-
Short-container-title:Geospat Health
Author:
Andrianto Andrianto, Muharram Farizal RizkyORCID, Multazam Chaq El Chaq Zamzam, Socha Wigaviola, Firman Doni, Romdhoni Ahmad Chusnu, Salsabilla Senitza Anisa
Abstract
Coronary heart disease is a non-communicable disease whose treatment is closely related to infrastructure, such as diagnostic imaging equipment visualizing arteries and chambers of the heart (cath lab) and infrastructure that supports access to healthcare. This research is intended as a preliminary geospatial study to carry out initial measurements of health facility coverage at the regional level, survey available supporting data and provide input on problems in future research. Data on cath lab presence was gathered through direct survey, while population data was taken from an open-source geospatial system. The cath lab service coverage was obtained by analysis based on a Geographical Information System (GIS) specific tool to evaluate travel time from the sub-district centre to the nearest cath lab facility. The number of cath labs in East Java has increased from 16 to 33 in the last six years and the 1-hour access time increased from 24.2% to 53.8%. However, accessibility remains a problem as16.5% of the total population of East Java cannot access a cath lab even within 2 hours. Thus, additional cath lab facilities are required to provide ideal healthcare coverage. Geospatial analysis is the tool to determine the optimal cath lab distribution.
Publisher
PAGEPress Publications
Subject
Health Policy,Geography, Planning and Development,Health (social science),Medicine (miscellaneous)
Reference14 articles.
1. Ahmat A, Asamani JA, Abdou Illou MM, Millogo JJS, Okoroafor SC, Nabyonga-Orem J, Karamagi HC, Nyoni J. 2021. Estimating the threshold of health workforce densities towards universal health coverage in Africa. BMJ Glob Health 7:e008310. 2. Aminorroaya A, Yoosefi M, Rezaei N, Shabani M, Mohammadi E, Fattahi N, Azadnajafabad S, Nasserinejad M, Rezaei N, Naderimagham S, Ahmadi N, Ebrahimi H, Mirbolouk M, Blaha MJ, Larijani B, Farzadfar F. 2022. Global, regional, and national quality of care of ischaemic heart disease from 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017. Eur J Prev Card 29:371–379. 3. Barbato E, Noc M, Baumbach A, Dudek D, Bunc M, Skalidis E, Banning A, Legutko J, Witt N, Pan M, Tilsted HH, Nef H, Tarantini G, Kazakiewicz D, Huculeci R, Cook S, Magdy A, Desmet W, Cayla G, Vinereanu D, Voskuil M, Goktekin O, Vardas P, Timmis A, Haude M. 2020. Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas Project. Eur Heart J 41:2579–88. 4. Baumgartner H, Falk V, Bax J, Bonis M, Hamm C, Holm P, Kung B, Lancellotti P, Lansac E, Munoz D, Rosenhek P, Sjorgen J, Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano J. 2017. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2786. 5. Concannon T, Nelson J, Goetz, Griffith J. 2012. A Percoutaneous Coronary Intervention Lab in Every Hospital? Circulation Cardiovascular Quality Outcomes 5:14-20.
|
|